NASDAQ
Harmony Biosciences Holdings, Inc. (HRMY) has a price/fcf ratio of 6.18x as of Monday, May 25, 2026. This represents a 62.11% decrease compared to its 12-month average of 16.32x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.